CBG vs CBD

CBG is also known as “the mother of all cannabinoids.” In the earliest stages of its life, a cannabis plant produces cannabigerolic acid (CBGA). As the plant starts to grow, it breaks down CBGA and turns it into tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), and cannabichromenic acid (CBCA).

Then, the acid forms of each compound turn into the substances we know: CBDA becomes CBD, THCA becomes THC, and CBCA turns into CBC. Because of the way the plant converts CBGA during its life cycle, it’s challenging to extract large amounts of CBG from hemp. Most hemp plants have less than 1% CBG at harvest time.

CBD and CBG are non-psychoactive, which means they don’t create the “high” that’s associated with THC. Just like CBD, CBG could potentially have a wide range of positive effects. However, there haven’t been many studies, so the available info is pretty limited compared to the huge amount of research on CBD and THC.

Which is better, CBD or CBG?

As mentioned before, CBG is crucial for the production of CBD. CBD stands for cannabidiol. It’s a non-intoxicating natural compound that comes from the Cannabis sativa (hemp) plant. Neither CBD nor CBG gives you a high.

So, they have some things in common, but since both cannabinoids are different compounds within the cannabis plant, they serve different purposes. Future studies won’t just focus on the possible effects that CBD or CBG might have on the human body separately, but also on how the two can be used together.

Both compounds are incredibly versatile when it comes to how they’re used. It really depends on what effect you’re hoping for. However, only a few cannabis strains have enough CBG, which makes it harder to extract. Still, there are plenty of innovative growers working on plants with higher CBG yields, so there’s hope that soon their output could match that of CBD. There are already lots of products out there that contain both CBD and CBG.

Research on CBD and CBG

The academic world is still at the very beginning when it comes to research on medical marijuana. Because it’s classified as a Schedule I substance, research on cannabinoids and marijuana in the US is limited. Researchers have gathered way more info about CBD than CBG. But in the future, CBG will definitely get more attention in studies.